Coronavirus

 
Immunization in America: Highs and Lows by State
April 23, 2025

A quick look at the states ranking highest and lowest on metrics including influenza vaccination, tetanus vaccination, HPV vaccination, and more.

Novavax JN.1 COVID-19 Vaccine Linked to Fewer Side Effects Than mRNA in Health Care Workers
April 22, 2025

Novavax’s COVID-19 vaccine was linked to fewer and less severe side effects vs mRNA in a University of Utah study of health care workers.

COVID-19 Associated with Higher Long-Term Mortality Than Flu or RSV: New Data
February 03, 2025

Researchers found that COVID-19 had a higher long-term mortality than influenza and RSV in veterans—underscoring vaccination’s vital role.

Sen-Jam Pharmaceutical Reports Preliminary Phase 2 Results for SJP-002C in COVID-19 Treatment
January 20, 2025

The novel therapeutic demonstrated a strong safety profile and showed efficacy in reducing symptoms during the early stages of treatment.

US Adults Lagging in Flu, COVID-19, and RSV Vaccination: Daily Dose
December 18, 2024

Your daily dose of the clinical news you may have missed.

The Biggest Challenge with COVID-19 Right Now: An Interview with NFID Medical Director Robert Hopkins, Jr, MD
December 12, 2024

Hopkins, of the National Foundation for Infectious Diseases, is frustrated by the diminished societal response to the virus' circulation including ongoing low vaccination rates.

New COVID-19 Vaccination Guidance for Older Adults & High-Risk Groups: A Conversation with NFID Medical Director Robert Hopkins, Jr, MD
December 09, 2024

Guidance from the Advisory Committee on Immunization Practices on best practices for COVID-19 vaccination continues to evolve, Hopkins explained.

Pandemic Medical Misinformation Has Not Prompted Disciplinary Action: Daily Dose
November 29, 2024

Your daily dose of the clinical news you may have missed.

Pandemic Medical Misinformation Has Not Prompted Disciplinary Action, Study Reveals
November 13, 2024

Little action has been taken by state medical boards against clinicians who spread unsubstantiated claims about COVID-19, vaccines, or other pandemic-related topics.

FDA Lifts Clinical Hold on Novavax’s COVID-19-Influenza Combination Vaccine
November 12, 2024

The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.